Advent Seeks CCI Approval for Yatharth Hospitals Stake
Advent International has approached the Competition Commission of India to acquire a minority stake in Yatharth Hospitals. Therefore, the proposed Yatharth Hospitals investment marks a significant expansion of private capital into northern India's hospital sector. The transaction will proceed through Advent's Cyprus-based investment vehicle, Rasmalai Limited.
Consequently, this regulatory submission follows a definitive agreement announced last month. Under this agreement, Advent agreed to invest Rs 3,150 crore of primary capital into the healthcare chain. In exchange, the investor will receive a 24.9 per cent minority equity stake.
Details of the Yatharth Hospitals Investment
Specifically, Rasmalai Limited submitted the combination notice to the fair trade regulator earlier this week. Both parties stated that the proposed transaction will not cause an appreciable adverse effect on market competition. Moreover, the regulatory filing identified the relevant market as the retail sale of pharmaceutical products in India.
Furthermore, the hospital network intends to utilize this substantial capital infusion to fund strategic growth initiatives. The primary capital will support new hospital projects and upgrade existing clinical infrastructure. As a result, the healthcare provider aims to consolidate its presence across target regional markets, supported by professionals trained through a comprehensive general practice curriculum.
Expansion Plans and Healthcare Infrastructure
Established in 2008, Noida-based Yatharth Hospital and Trauma Care Services has grown rapidly across northern India. Currently, the company operates nine multi-speciality tertiary care facilities with 2,800 operational beds. In addition, the organization has announced plans to expand its total bed capacity to 3,250 beds.
Meanwhile, clinical specialists anticipate that modern private equity partnerships will enhance tertiary care access. Large capital reserves enable corporate hospital chains to deploy advanced diagnostic equipment and modern surgical platforms. Therefore, these investments may attract top clinical talent and enhance specialized healthcare delivery across regional centres, aligning with advancements taught in intensive care medicine programs.
Frequently Asked Questions
Q1: What percentage stake is Advent International acquiring in Yatharth Hospitals?
Advent International plans to acquire a 24.9 per cent minority stake through its investment vehicle Rasmalai Limited.
Q2: How much primary capital will the transaction bring into the hospital chain?
Under the definitive agreement, Advent International will invest Rs 3,150 crore of primary capital into Yatharth Hospitals.
Q3: Why is Competition Commission of India clearance required for this deal?
Indian competition law mandates regulatory clearance for substantial corporate acquisitions to ensure fair competition across relevant healthcare markets.
References
- Advent International seeks CCI nod to acquire minority stake in YatharthHospitals - ETHealthworld
- Competition Commission of India - Notice of Combination under Section 6 of the Competition Act, 2002
- Press Trust of India - Advent International seeks CCI nod to acquire minority stake in Yatharth Hospitals
